Navigation Links
Eli Lilly & Company and ScinoPharm Taiwan Ltd. Announce Settlement of Gemcitabine Litigation
Date:7/30/2009

TAINAN, Taiwan, July 30 /PRNewswire-Asia/ -- Eli Lilly & Company ("Lilly") and ScinoPharm Taiwan Ltd. ("ScinoPharm") announced today that they have reached an amicable resolution of all ongoing patent litigations between the companies relating to ScinoPharm's manufacture and sale of gemcitabine hydrochloride around the world.

As part of the settlement, Lilly has granted ScinoPharm a royalty bearing license to manufacture and sell gemcitabine hydrochloride (API) throughout the world, excluding only countries where the Lilly compound or method of use patents remain in force and the United States.

About ScinoPharm Taiwan Ltd.

ScinoPharm Taiwan Ltd. is a leading process R&D and API manufacturing service provider to the global pharmaceutical industry. With cGMP production facilities, ScinoPharm offers a wide portfolio of services ranging from custom synthesis for early phase pharmaceutical activities to brand companies as well as APIs for the generic industry. Combining cost-effective resources and productivity of Asia along with extensive regulatory know-how, ScinoPharm is uniquely positioned to serve global pharmaceutical R&D and manufacturing needs at any level and for any company in this sector. For more information please visit http://www.scinopharm.com .

About Eli Lilly & Company

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Indiana, Lilly provides answers -- through medicines and information -- for some of the world's most urgent medical needs. Additional information about Lilly is available at http://www.lilly.com .


'/>"/>
SOURCE ScinoPharm Taiwan, Ltd.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Emisphere Technologies, Inc. and Eli Lilly and Company Settle Ongoing Litigation
2. Lilly Declares Fourth-Quarter Dividend
3. Robert Conley, M.D. to Join Lilly; Will assume a neuroscience leadership role as a Distinguished Lilly Scholar
4. Lilly and BioMS Medical Announce Global Licensing and Development Agreement
5. Daiichi Sankyo, Lilly Submit New Drug Application for Investigational Antiplatelet Drug, Prasugrel, with U.S. Food and Drug Administration
6. In response to a New England Journal of Medicine article published yesterday and subsequent media coverage, Eli Lilly and Company issued the following statement:
7. Lilly Announces Termination of AIR Insulin Program
8. HistoRx and Lilly Extend, Expand AQUA(R) Analysis Partnership
9. Pelikan Technologies and Lilly Form Alliance to Promote Diabetes Education
10. Lilly Reports Solid First-Quarter Results
11. Lilly CEO Praises Massachusetts Leadership in Biotech, Urges Policy Prescriptions to Help Ensure States Investment Generates Dividends and Jobs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... Pharmaceuticals, Inc. (Nasdaq: PPHM ) today reported completion ... trial of Cotara® in patients with relapsed glioblastoma multiforme ... is a targeted monoclonal antibody linked to a radioisotope ... Cotara specifically targets cells at the center of ...
(Date:12/2/2009)... TechConnect World, an event bringing together the leaders ... nanotech, biotech and MEMS, announced the December 11th ... Now in its 14th year, TechConnect World, in ... (NSTI), and the Clean Technology and Sustainable Industries ...
(Date:12/2/2009)... /PRNewswire-Asia/ -- Simcere Pharmaceutical Group,("Simcere" or the "Company") ... company,specializing in the development, manufacturing, and marketing of ... that 105 of,its drugs have been included in ... by China,s Ministry of Human Resources and Social,Security ...
(Date:12/2/2009)... 2 According to the National Institute of Health, 40 ... have some stage of diabetic retinopathy. Diabetic retinopathy, damage ... major cause of blindness in people with diabetes and is ... up to 80 percent of all patients who,ve had diabetes ...
Breaking Biology Technology:Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 3Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 2Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 4
... - IntelliPharmaCeutics Ltd. (Delaware),is pleased to announce ... trial for its new abuse-resistant, alcohol-resistant once-a-day,oral ... of Toronto ("IntelliPharmaCeutics" or the "Company"). The ... its novel ReXista(TM) abuse and,alcohol resistant drug ...
... March 27 Core Informatics announces,that it ... web-based,Laboratory Information Management System (LIMS) product, the ... PGNX ), a biopharmaceutical,company located in Tarrytown, ... legacy data migration from its previous data ...
... and Enforceable in 24 European ... Countries, - Competitors Precluded from Immediate ... ... Neptune Technologies &,Bioressources Inc. ("Neptune") (NASDAQ.NEPT - TSX.V.NTB) announces that the,European Patent Office (EPO) ...
Other Biology Technology:IntelliPharmaCeutics Announces Successful Completion of a Pilot Clinical Trial for its Abuse and Alcohol Resistant Sustained Release Oxycodone 2IntelliPharmaCeutics Announces Successful Completion of a Pilot Clinical Trial for its Abuse and Alcohol Resistant Sustained Release Oxycodone 3Neptune Technologies patent granted for novel phospholipids in multiple diseases and pharmaceutical applications 2Neptune Technologies patent granted for novel phospholipids in multiple diseases and pharmaceutical applications 3
(Date:12/3/2009)... , , Preliminary Press Conference Topics, Last ... Sciences museum, Attention PIOs: Sending Press Releases to ... 10 December, News Media registration information , News ... December, Who,s coming, , For important information ...
(Date:12/3/2009)... by a social snubbing? Your genetics, not your friends, may ... painkillers, called opioids, relieve not only physical pain, but also ... by Faculty of 1000 Biology member Markus Heilig shows that ... can determine the intensity of people,s responses to social rejection. ...
(Date:12/3/2009)... Antarctic snowmelt that occurred during the 2008-09 austral summer ... two main climate drivers, ENSO (El Nio - Southern ... Dr. Marco Tedesco, Assistant Professor of Earth & Atmospheric ... , Professor Tedesco, who is also on the ...
Breaking Biology News(10 mins):AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 2AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 3AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 4AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 5AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 6CCNY professor foresees rising Antarctic snowmelt 2Medizone International Inc Announces OTCBB Listing 56389 1Medizone International Inc Announces OTCBB Listing 56389 21 200 Nurses Make a House Call to Dianne Feinstein To Demand She Cosponsor Employee Free Choice Act 56384 11 200 Nurses Make a House Call to Dianne Feinstein To Demand She Cosponsor Employee Free Choice Act 56384 2PAREXEL International to Present at Thomas Weisel Partners Healthcare Conference 13893 1PAREXEL International to Present at Thomas Weisel Partners Healthcare Conference 13893 2
... hand-in-hand with enlargement of a brain region that handles negative ... Texas Veterans Health Care System have found. , ... and contains more nerve cells in humans who carry the ... regions that receive input from the pulvinar are more strongly ...
... lifespans, which means that they must be continually replaced ... blood cell types needed by the body. Claus ... Laboratory (EMBL) unit in Monterotondo, Italy, in collaboration with ... of Lund in Sweden, have now uncovered how an ...
... space create in humans and animals so-called optical flow fields ... forward movement, the objects flow by laterally, objects at the ... at all. At a higher level in the visual centre ... visual information, so that animals can differentiate between their own ...
Other Biology News:Gene linked with mental illness shapes brain region, researchers find 2Lost in the labyrinth 2Two nerve cells in direct contact 2Two nerve cells in direct contact 3
... Sciences can provide custom microplate coating using advanced automated high ... of plate formats. We can also accommodate virtually any lot ... 0.5-320 L):, , 8 ... well microplate, 384 well microplate, ...
... HRP Conjugation Kits are based on ... that are consistent and reproducible. This ... conjugate your protein or antibody, including ... buffer. Activated HRP is supplied ...
... Acridinium NHS ester can be ... nucleic acids. The covalently bound ... chemiluminescence in the presence of ... proteins can be used as ...
... up to 6 strain chambers with precise uniaxial ... design ensures that cells grow over long periods ... This unit allows you to control the frequency ... unique strain settings. The instrument fits in a ...
Biology Products: